Sign in
8-K

Current Report

Bolt Biotherapeutics, Inc. Filed Acc 0000950170-24-059524

Acquisition or sale completed · Exit or restructuring costs · Executive or director change

  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 2.05 Costs associated with exit or disposal activities
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading bolt-20240513.htm…